Senores Pharmaceuticals Limited has entered into a Loan Agreement dated December 20, 2025, with Apnar Pharma Private Limited (“Apnar”) for granting an inter-corporate loan of up to ₹15,00,00,000/- (Rupees Fifteen Crores Only). This loan facility will be disbursed in one or more tranches. The loan is unsecured, and the interest rate is set at an arm's length basis of 10% per annum on the outstanding loan amount. The loan is repayable on demand, with all outstanding amounts becoming immediately due and payable upon such demand. Apnar has the flexibility to pre-pay the loan amount if mutually agreed upon by both parties. The disbursed loan funds are intended to be utilized by Apnar for discharging and/or paying off its liabilities as previously mentioned in the Share Purchase Agreement dated December 15, 2025, between Senores Pharmaceuticals Limited and Apnar Pharma Private Limited. As of the disclosure date, December 20, 2025, the total outstanding loan amount is ₹1,00,00,000/- (Rupees One Crore Only), which is part of an earlier granted loan of ₹1,50,00,000/-. The parties involved are not related to each other as of the loan agreement date.